Chen, Ke-Liang Sun, Yi-Min Zhou, Yan Zhao, Qian-Hua Ding, Ding and Guo, Qi-Hao 2016. Associations between APOE polymorphisms and seven diseases with cognitive impairment including Alzheimer’s disease, frontotemporal dementia, and dementia with Lewy bodies in southeast China. Psychiatric Genetics, Vol. 26, Issue. 3, p. 124.
Delli Pizzi, Stefano Franciotti, Raffaella Bubbico, Giovanna Thomas, Astrid Onofrj, Marco and Bonanni, Laura 2016. Atrophy of hippocampal subfields and adjacent extrahippocampal structures in dementia with Lewy bodies and Alzheimer's disease. Neurobiology of Aging, Vol. 40, p. 103.
Firbank, Michael Kobeleva, Xenia Cherry, George Killen, Alison Gallagher, Peter Burn, David J. Thomas, Alan J. O'Brien, John T. and Taylor, John-Paul 2016. Neural correlates of attention-executive dysfunction in lewy body dementia and Alzheimer's disease. Human Brain Mapping, Vol. 37, Issue. 3, p. 1254.
Flanagan, Margaret Larson, Eric B. Latimer, Caitlin S. Cholerton, Brenna Crane, Paul K. Montine, Kathleen S. White, Lon R. Keene, C. Dirk and Montine, Thomas J. 2016. Clinical-pathologic correlations in vascular cognitive impairment and dementia. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Vol. 1862, Issue. 5, p. 945.
Haller, Sven Fällmar, David and Larsson, Elna-Marie 2016. Susceptibility weighted imaging in dementia with Lewy bodies: will it resolve the blind spot of MRI?. Neuroradiology, Vol. 58, Issue. 2, p. 217.
Hindle, John V Watermeyer, Tamlyn J Roberts, Julie Martyr, Anthony Lloyd-Williams, Huw Brand, Andrew Gutting, Petra Hoare, Zoe Edwards, Rhiannon Tudor and Clare, Linda 2016. Cognitive rehabiliation for Parkinson's disease dementia: a study protocol for a pilot randomised controlled trial. Trials, Vol. 17, Issue. 1,
Llorens, Franc Schmitz, Matthias Varges, Daniela Kruse, Niels Gotzmann, Nadine Gmitterová, Karin Mollenhauer, Brit and Zerr, Inga 2016. Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies. Journal of Neurology,
Maloney, Bryan and Lahiri, Debomoy K 2016. Epigenetics of dementia: understanding the disease as a transformation rather than a state. The Lancet Neurology, Vol. 15, Issue. 7, p. 760.
Martin-Macintosh, Erica L. Broski, Stephen M. Johnson, Geoffrey B. Hunt, Christopher H. Cullen, Ethany L. and Peller, Patrick J. 2016. Multimodality Imaging of Neurodegenerative Processes: Part 1, The Basics and Common Dementias. American Journal of Roentgenology, Vol. 207, Issue. 4, p. 871.
McAllum, Erin J. and Finkelstein, David I. 2016. Metals in Alzheimer’s and Parkinson’s Disease: Relevance to Dementia with Lewy Bodies. Journal of Molecular Neuroscience,
Sarro, Lidia Tosakulwong, Nirubol Schwarz, Christopher G. Graff-Radford, Jonathan Przybelski, Scott A. Lesnick, Timothy G. Zuk, Samantha M. Reid, Robert I. Raman, Mekala R. Boeve, Bradley F. Ferman, Tanis J. Knopman, David S. Comi, Giancarlo Filippi, Massimo Murray, Melissa E. Parisi, Joseph E. Dickson, Dennis W. Petersen, Ronald C. Jack, Clifford R. and Kantarci, Kejal 2016. An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease. Alzheimer's & Dementia,
Tang, Eugene Yee Hing Burn, David Taylor, John-Paul and Robinson, Louise 2016. Dementia with Lewy bodies: The emerging role of primary care. European Journal of General Practice, Vol. 22, Issue. 1, p. 53.
Yue, Wei Wang, Xiao-Dan Shi, Zhihong Wang, Yajing Liu, Shuai Liu, Shuling Zhang, Ying Zhang, Yajing Lu, Hui Su, Wenhua and Ji, Yong 2016. The prevalence of dementia with Lewy bodies in a rural area of China. Parkinsonism & Related Disorders, Vol. 29, p. 72.
Boot, Brendon P 2015. Comprehensive treatment of dementia with Lewy bodies. Alzheimer's Research & Therapy, Vol. 7, Issue. 1,
Buckley, Jacob S. and Salpeter, Shelley R. 2015. A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence. Drugs & Aging, Vol. 32, Issue. 6, p. 453.
Catafau, Ana M. and Bullich, Santiago 2015. Amyloid PET imaging: applications beyond Alzheimer’s disease. Clinical and Translational Imaging, Vol. 3, Issue. 1, p. 39.
Colijn, Mark A. Nitta, Bradley H. and Grossberg, George T. 2015. Psychosis in Later Life. Harvard Review of Psychiatry, Vol. 23, Issue. 5, p. 354.
Delli Pizzi, Stefano Franciotti, Raffaella Taylor, John-Paul Esposito, Roberto Tartaro, Armando Thomas, Astrid Onofrj, Marco and Bonanni, Laura 2015. Structural Connectivity is Differently Altered in Dementia with Lewy Body and Alzheimer’s Disease. Frontiers in Aging Neuroscience, Vol. 7,
Donaghy, P. C. O'Brien, J. T. and Thomas, A. J. 2015. Prodromal dementia with Lewy bodies. Psychological Medicine, Vol. 45, Issue. 02, p. 259.
Frey, Kirk A. and Petrou, Myria 2015. Imaging amyloidopathy in Parkinson disease and parkinsonian dementia syndromes. Clinical and Translational Imaging, Vol. 3, Issue. 1, p. 57.
Dementia with Lewy bodies (DLB) is increasingly recognized as a common cause of dementia in older people. However, its true frequency remains unclear, with previous studies reporting a prevalence range from zero to 22.8% of all dementia cases. This review aimed to establish the population prevalence and incidence for DLB and to compare this to its prevalence in secondary care settings.
A literature review of all relevant population and clinical studies was conducted using PubMed. Additional references from papers found during that process were added to this.
DLB accounted for 4.2% of all diagnosed dementias in the community. In secondary care this increased to 7.5%. The incidence of DLB was 3.8% of new dementia cases. There was a significant increase in DLB diagnoses when using the revised (2005) International Consensus Criteria (ICC) for DLB compared to the original (1996) criteria.
DLB currently accounts for around one in 25 dementia cases diagnosed in the community and one in 13 cases in secondary care. The significantly higher rates of DLB in secondary care may reflect enhanced diagnostic accuracy in specialist settings and/or the increased morbidity and carer burden of the DLB syndrome compared to other dementias. However, the true prevalence is likely to be much higher because DLB diagnoses are often missed, although there is evidence that new criteria aid case identification.
This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.